• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Phyo K. Myint, MD

Latest:

Predicting Mortality Risk Using the PREVENT Equation Across Diverse Racial Groups

This study validates the Predicting Risk of CVD Events (PREVENT) score across diverse racial and ethnic populations, highlighting its effectiveness in predicting cardiovascular risk and mortality, regardless of race or ethnicity.


Richard Schwartz, BS

Latest:

Post-SNF Outcomes and Cost Comparison: Medicare Advantage vs Traditional Medicare

Patients enrolled in Medicare Advantage had better outcomes and lower cost following skilled nursing facility (SNF) discharge than patients enrolled in traditional fee-for-service Medicare.


Kimberly J. Erlich, MSN, MPH, RN, CPNP, PMHS

Latest:

Primary Care Nurse Practitioner Management of Adolescent Behavioral Health

Personnel costs ($90,514) of a primary care–embedded adolescent behavioral health nurse practitioner over 2 years were 63% of the potential revenue generated ($144,449).


Kenneth C. Hohmeier, PharmD

Latest:

Amazon Pharmacy: Distraction or Disruption?

After years of anticipation, Amazon Pharmacy launched in November 2020. The question is now: Is this market entry a disruption, a distraction, or something in between?


Cathy Eng, MD, FACP, FASCO | Image Credit: © Vanderbilt-Ingram Cancer Center
Cathy Eng, MD, FACP, FASCO

Latest:

We Do Our Best to Serve the Community: Cathy Eng, MD, FACP, FASCO

Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center, speaks about the clinical and operational priorities that academic medical centers make front-and-center when caring for underserved populations receiving treatment for cancer.


David M. Miller, MBA

Latest:

A Standardized Care Pathway Increases Optimal Dialysis Starts

The authors observed a significant increase in optimal starts for dialysis and in peritoneal dialysis rates after implementing a standardized end-stage renal disease transition pathway.


Jordan Rosedahl, BS

Latest:

Impact of Advance Care Planning Consults on Advance Directives Completion

Implementing advance care planning consults can increase advance directive completion rates. The authors demonstrate the impact of consults on completed advance directives in the medical record.


Aisha T. Langford, PhD, MPH

Latest:

When Does Nonadherence Indicate a Deviation From Patient-Centered Care?

The authors suggest that assessment of patient-centered care may be improved by flagging probable discordance between a patient’s preferences and their treatment care plan.


Katherine Koh, MD, MSc

Latest:

Multisector Approach Best for Reducing Homeless Individuals in the Streets: Katherine Koh, MD, MSc

Approaching homelessness through prevention and local government policies is the next step in addressing increased incidence of homelessness, said Katherine Koh, MD, MSc.


Roy G. Marcus, MD

Latest:

A Standardized Care Pathway Increases Optimal Dialysis Starts

The authors observed a significant increase in optimal starts for dialysis and in peritoneal dialysis rates after implementing a standardized end-stage renal disease transition pathway.


Millie Mo, PharmD

Latest:

Navigating Compounded Semaglutide: What Health Care Providers Need to Know

This article reviews the safety, efficacy, and regulatory concerns related to compounded semaglutide, with a focus on how health care providers can offer guidance and education to patients.



Caleb J. Scheckel, DO

Latest:

Neulasta Onpro: A Coup de Grâce?

With the rapid decline in average sales price of reference pegfilgrastim products due to biosimilar competition, health care institutions and payers may grapple with coverage of Neulasta Onpro.


Brianna Rhue, OD, FAAO

Latest:

Experts Recount What Aspects of SECO Will Be Vital to Their Future Practice

Attendees and experts from the Southeastern Educational Congress of Optometry (SECO) 2025 meeting highlight research and sessions they will take away.


Jason Harris

Latest:

FDA Fast Tracks BCMA-Targeted CAR T-Cell Therapy for R/R Multiple Myeloma

The FDA has granted a fast track designation to CB-011, a CRISPR-edited allogeneic CAR T-cell therapy developed by Caribou Biosciences, for the treatment of patients with relapsed/refractory multiple myeloma.


Christopher M. Whinney, MD

Latest:

The Relationship Between the Follow-up to Discharge Ratio and Length of Stay

The objective was to evaluate the correlation between the follow-up to discharge ratio and average length of stay.


Maulik Majmudar, MD

Latest:

Final Thoughts on Arrhythmia Management

Experts agree that developing value-based care models for atrial fibrillation requires collaborative, data-driven strategies—leveraging clinical pharmacists for personalized medication management and prioritizing stroke prevention and rhythm control—while embracing innovation and workforce redesign to balance quality, cost-effectiveness, and avoid overdiagnosis in an evolving health care landscape.


Charles Maynard, PhD, MSW

Latest:

Factors Associated With Primary Care Physician Turnover in the VA

This longitudinal observational study found higher team satisfaction with workload to be significantly associated with lower primary care physician turnover.


Yale Podnos, MD, MPH, FACS

Latest:

Addressing Social Determinants of Health Through Value-Based Oncology Care: Yale Podnos, MD, MPH, FACS

Yale Podnos, MD, MPH, FACS, discusses strategies to address social determinants of health in oncology, improve clinical trial enrollment for underserved communities, and leverage value-based care models to reduce financial toxicity and ensure equitable cancer care.


Mitch Perry

Latest:

Contributor: For Better or Worse, Inflation Isn’t New to Health Insurers

In this column, a health insurance executive discusses 2 ways to address rising inflation, including moving past the traditional fee-for-service payment model.


Ryan Scott

Latest:

Neoadjuvant KN026 Plus Docetaxel Demonstrate Early Activity in HER2+ Breast Cancer

A combination of KN026, a novel bispecific antibody, and docetaxel elicited responses with an acceptable toxicity profile when administered as neoadjuvant treatment in patients with HER2-positive (HER2+) early or locally advanced breast cancer.


Ryan Nguyen, PharmD, BCPS

Latest:

Pharmacist-Led Review of Empagliflozin and Ertugliflozin Following Formulary Update

Management of empagliflozin and ertugliflozin may be suboptimal following an insurance carrier’s formulary updates. Pharmacists may improve the management.


Portia J. Zaire, PhD, RN

Latest:

Navigation and Clinician Payment Investments Enhance Colorectal Cancer Screening Benefits

Investing in patient navigation and clinician incentives ensures colorectal cancer screening completion, improves early detection, reduces disparities, achieves cost savings, and advances population health for all stakeholders.


Jaehyeon Yun, PhD

Latest:

Predicting Hospital Readmission in Medicaid Patients With Diabetes Using Administrative and Claims Data

A statistical model based entirely on claims data can accurately predict 30-day hospital readmission in Medicaid patients with diabetes.


Scott E. Regenbogen, MD, MPH

Latest:

Hospital Strategies in Commercial Episode-Based Reimbursement

This study reports qualitative findings from an explanatory sequential mixed-methods investigation to understand hospitals’ approaches to a novel commercial episode-based reimbursement incentive program.


Seth Killion, BS

Latest:

Effects of Individualized Nurse-Led Care Plans on Olaparib Treatment Duration

A nurse-led personalized care program conducted through a specialty pharmacy prolonged medication persistence among patients with cancer receiving olaparib.



Grazia Aleppo, MD

Latest:

The Role of Advanced Technologies in Improving Diabetes Outcomes

This article reviews underlying barriers to health care access and discusses how a value-based diabetes care model could improve patient outcomes and reduce long-term costs.



© 2025 MJH Life Sciences
AJMC®
All rights reserved.